These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34958881)

  • 1. Approaches to endocrinopathic laminitis in the field: Results of a survey of veterinary practitioners in North America.
    Rumfola E; Banse HE; Atkins M; McGowan CM; Ireland JL
    J Equine Vet Sci; 2022 Mar; 110():103856. PubMed ID: 34958881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
    de Laat MA; Reiche DB; Sillence MN; McGree JM
    J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacologic basis for the treatment of endocrinopathic laminitis.
    Durham A
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):303-14. PubMed ID: 20699177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field treatment and management of endocrinopathic laminitis in horses and ponies.
    Walsh DM
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):379-90. PubMed ID: 20699182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinopathic laminitis.
    McGowan CM
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):233-7. PubMed ID: 20699171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating research into practice: Adoption of endocrine diagnostic testing in cases of equine laminitis.
    Ireland JL; McGowan CM
    Vet J; 2021 Jun; 272():105656. PubMed ID: 33941328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinopathic Laminitis.
    Grenager NS
    Vet Clin North Am Equine Pract; 2021 Dec; 37(3):619-638. PubMed ID: 34674908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
    Karikoski NP; Horn I; McGowan TW; McGowan CM
    Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of cellular and molecular mechanisms in endocrinopathic, sepsis-related and supporting limb equine laminitis.
    Elliott J; Bailey SR
    Equine Vet J; 2023 May; 55(3):350-375. PubMed ID: 36847165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigm shifts in understanding equine laminitis.
    Patterson-Kane JC; Karikoski NP; McGowan CM
    Vet J; 2018 Jan; 231():33-40. PubMed ID: 29429485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science in brief: Progress in endocrinopathic laminitis research: Have we got a foothold?
    de Laat MA
    Equine Vet J; 2019 Mar; 51(2):141-142. PubMed ID: 30724398
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminitis and the equine metabolic syndrome.
    Johnson PJ; Wiedmeyer CE; LaCarrubba A; Ganjam VK; Messer NT
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):239-55. PubMed ID: 20699172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECEIM consensus statement on equine metabolic syndrome.
    Durham AE; Frank N; McGowan CM; Menzies-Gow NJ; Roelfsema E; Vervuert I; Feige K; Fey K
    J Vet Intern Med; 2019 Mar; 33(2):335-349. PubMed ID: 30724412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet.
    Delarocque J; Reiche DB; Meier AD; Warnken T; Feige K; Sillence MN
    BMC Vet Res; 2021 Jan; 17(1):56. PubMed ID: 33509165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does oral prednisolone treatment increase the incidence of acute laminitis?
    Jordan VJ; Ireland JL; Rendle DI
    Equine Vet J; 2017 Jan; 49(1):19-25. PubMed ID: 26713748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of a new laminitis scoring method to model the rate and pattern of improvement from equine endocrinopathic laminitis in a clinical setting.
    Meier A; McGree J; Klee R; Preuß J; Reiche D; de Laat M; Sillence M
    BMC Vet Res; 2021 Jan; 17(1):16. PubMed ID: 33413384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
    Wylie CE; Collins SN; Verheyen KL; Newton JR
    Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.